Pharma Journalist -

The U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and…
Read More...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced at Vaxart’s key opinion…
Read More...

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings…
Read More...

Revive Therapeutics Ltd. a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it…
Read More...

Hoth Therapeutics, Inc. a patient-focused clinical-stage biopharmaceutical company, announced it intends to pursue development of its HT-KIT mRNA Frame Shifting Therapeutic for multiple…
Read More...

Jacobio Pharmaceuticals has announced  the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor.…
Read More...

Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific E-CFEG, the company's new cold field emission gun and a value-added component for the…
Read More...

Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening…
Read More...

Mesoblast Limited announced the 60 day results from the randomized controlled trial of remestemcel-L in 222 ventilator-dependent COVID-19 patients with moderate/severe acute respiratory…
Read More...

osteolabs GmbH announces the formation of osteolabs UK Limited in Marlow near London. osteolabs UK is a Joint Venture between osteolabs GmbH as majority shareholder and Christopher…
Read More...